Minnesota Gov. Proposes Groundbreaking Marijuana Research

Although 20 states and Washington, D.C., have legalized medical marijuana, Dayton has been reluctant to listen to patients and medical professionals, opting to mostly hear law enforcement’s view on the issue.

In his proposal, Dayton suggested the state allocate $2.2 million for a study at the Minnesota-based Mayo Clinic to specifically examine how marijuana’s non-psychoactive ingredient, cannabidiol, or CBD, can be used to help children with various forms of epilepsy.

The study would involve about 200 children ages 1 to 18, Dayton said, but it would not examine any other medical conditions that could be helped by the use of medical marijuana such as AIDS, post-traumatic stress disorder or the effects of chemotherapy. Medicinal benefits of the psychoactive ingredient THC would also not be studied.

It is not known how long it would take for the study to be conclusive in Dayton and law enforcement’s projection, nor is it known whether the federal government would allow the Mayo Clinic to study the medicinal benefits of marijuana, since any study would require federal approval and federally-grown and -approved plants.

Heather Azzi, political director for the medical marijuana advocacy group Minnesotans for Compassionate Care, told MintPress News that Dayton has also expressed interest in studying pharmaceutical products derived from the marijuana plant that were created overseas.

To read more, visit http://www.mintpressnews.com/minn-gov-proposes-groundbreaking-marijuana-research/187396/

Posted in: Investing

Comments are closed.